Clinical Trials List
Protocol NumberOB-401
Completed
2013-12-01 - 2017-10-30
Phase III
Terminated1
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
- 溫文才 Division of Cardiovascular Diseases
- Tsung-Hsien Lin Division of Cardiovascular Diseases
- 許栢超醫師 Division of Cardiovascular Diseases
- Cheng-An Chiu Division of Cardiovascular Diseases
- 鄭凱鴻 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
120 participants
-
Global
16000 participants
